Maccura Biotechnology Co Stock Current Asset
| 300463 Stock | 13.94 0.07 0.50% |
Maccura Biotechnology Co fundamentals help investors to digest information that contributes to Maccura Biotechnology's financial success or failures. It also enables traders to predict the movement of Maccura Stock. The fundamental analysis module provides a way to measure Maccura Biotechnology's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Maccura Biotechnology stock.
The current year's Other Current Assets is expected to grow to about 175.1 M, whereas Total Current Assets are forecasted to decline to about 3.6 B. Maccura | Current Asset |
Maccura Biotechnology Co Company Current Asset Analysis
Maccura Biotechnology's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
| Competition |
Maccura Total Assets
Total Assets |
|
In accordance with the recently published financial statements, Maccura Biotechnology Co has a Current Asset of 0.0. This indicator is about the same for the Life Sciences Tools & Services average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all China stocks average (which is currently at 0.0).
Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
| All Next | Launch Module |
Maccura Fundamentals
| Return On Equity | 0.0485 | ||||
| Return On Asset | 0.0219 | ||||
| Profit Margin | 0.12 % | ||||
| Operating Margin | 0.17 % | ||||
| Current Valuation | 8.38 B | ||||
| Shares Outstanding | 612.47 M | ||||
| Shares Owned By Insiders | 40.27 % | ||||
| Shares Owned By Institutions | 4.76 % | ||||
| Price To Book | 1.31 X | ||||
| Price To Sales | 3.16 X | ||||
| Revenue | 2.9 B | ||||
| Gross Profit | 1.96 B | ||||
| EBITDA | 613.34 M | ||||
| Net Income | 312.62 M | ||||
| Total Debt | 144.65 M | ||||
| Book Value Per Share | 10.79 X | ||||
| Cash Flow From Operations | 901.51 M | ||||
| Earnings Per Share | 0.53 X | ||||
| Target Price | 13.79 | ||||
| Number Of Employees | 3.36 K | ||||
| Beta | 0.38 | ||||
| Market Capitalization | 8.61 B | ||||
| Total Asset | 8.12 B | ||||
| Retained Earnings | 3.84 B | ||||
| Working Capital | 3.1 B | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 8.12 B | ||||
| Last Dividend Paid | 0.15 |
About Maccura Biotechnology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Maccura Biotechnology Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Maccura Biotechnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Maccura Biotechnology Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Maccura Stock
Maccura Biotechnology financial ratios help investors to determine whether Maccura Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Maccura with respect to the benefits of owning Maccura Biotechnology security.